Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface (Q40609308)
Jump to navigation
Jump to search
scientific article published on December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface |
scientific article published on December 2003 |
Statements
1 reference
Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface (English)
1 reference
P Rod Dunbar
1 reference
Vincenzo Cerundolo
1 reference
Linda Wooldridge
1 reference
Sarah L Hutchinson
1 reference
Ed M Choi
1 reference
Anna Lissina
1 reference
Emma Jones
1 reference
Fareed Mirza
1 reference
David A Price
1 reference
Andy K Sewell
1 reference
1 December 2003
1 reference
1 reference
171
1 reference
12
1 reference
6650-6660
1 reference
Identifiers
1 reference
1 reference